Stocktoria
ABVC BIOPHARMA, INC. ABVC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-11-09
ABVC BIOPHARMA, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $296,000 | $509,589 | $152,430 | $969,783 | $355,797 |
| Gross profit | — | $508,826 | -$149,607 | $683,368 | $350,711 |
| R&D expense | $121,085 | $179,272 | $1.1M | $2.7M | $1.0M |
| SG&A expense | $2.9M | $2.3M | $5.4M | $6.1M | $5.7M |
| Operating income | -$7.2M | -$4.7M | -$6.8M | -$15.1M | -$11.7M |
| Interest expense | — | — | $1.3M | $293,968 | $227,210 |
| Income tax | $24,154 | -$110,539 | $256,006 | $797,778 | $825,024 |
| Net income | -$7.9M | -$4.9M | -$7.8M | -$16.4M | -$12.8M |
| EPS (diluted) | $-0.39 | $-0.42 | $-1.80 | $-5.19 | $-0.51 |
| Operating cash flow | -$3.0M | -$1.8M | -$4.2M | -$7.4M | -$7.6M |
| Free cash flow | — | — | -$4.2M | -$7.5M | -$7.6M |
| Cash & equivalents | $681,480 | $248,382 | $60,155 | $85,265 | $5.8M |
| Inventory | — | — | — | — | $25,975 |
| Total assets | $21.1M | $7.5M | $7.8M | $9.6M | $13.7M |
| Total liabilities | $7.8M | $6.8M | $6.5M | $6.3M | $4.8M |
| Shareholders' equity | $13.3M | $1.2M | $1.6M | $3.2M | $8.9M |
Source: SEC EDGAR filings · CIK 0001173313 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.